MJardin Receives Cultivation and Processing License at Second Ontario Facility
TORONTO and DENVER, Feb. 19, 2020 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), […]
Wave Life Sciences to Present at the Cowen and Company 40th Annual Healthcare Conference
CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed […]
Galera Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference
MALVERN, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing […]
Great Lakes Reports Record Full Year Results
Full year net income from continuing operations of $55.7 million Backlog of $589.4 million at December 31, 2019OAK BROOK, Ill., Feb. […]
Vericel to Present at the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020
CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine […]
Cellectar Biosciences Announces CLR 131 Achieves Primary Efficacy Endpoints from Its Phase 2 CLOVER-1 Study in Relapsed/Refractory B-cell Lymphomas and Completion of the Phase 1 Relapsed/Refractory Multiple Myeloma Dose Escalation Study
42.8% ORR in multiple myeloma at the 75mCi total body dose42.0% ORR and 11% CRR in all non-Hodgkin’s lymphoma (NHL) […]
TSX News -
DIRTT to Participate in 41st Annual Raymond James Institutional Investors Conference
CALGARY, Alberta, Feb. 19, 2020 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”) (TSX: DRT, NASDAQ: DRTT), an interior construction […]
Ebix Declares 7.5 Cent Quarterly Dividend, Payable March 16, 2020, to Shareholders of Record March 2, 2020
JOHNS CREEK, Ga., Feb. 19, 2020 (GLOBE NEWSWIRE) — Ebix, Inc., (NASDAQ: EBIX) a leading international supplier of On-Demand software […]
Affimed to Present at the SVB Leerink 9th Annual Global Healthcare Conference
Heidelberg, Germany, February 19, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]
Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 25, 2020
DUBLIN, Ireland and TREVOSE, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical […]
